Hormone Levels in Women with Rheumatoid Arthritis
Author Information
Author(s): Marc R Blackman, Ranganath Muniyappa, Mildred Wilson, Barbara E Moquin, Howard L Baldwin, Kelli A Wong, Christopher Snyder, Michael Magalnick, Shaan Alli, James Reynolds, Seth M Steinberg, Raphaela Goldbach-Mansky
Primary Institution: National Institutes of Health
Hypothesis
Patients with active RA exhibit decreased GH/IGF-I axis activity.
Conclusion
Women with active RA show reduced levels of IGF-I and a trend towards GH insensitivity.
Supporting Evidence
- Patients with RA had lower IGF-I levels compared to controls.
- GH half-life was significantly shorter in RA patients.
- Lean body mass was lower in patients with RA, especially in the legs.
Takeaway
This study looked at hormone levels in women with rheumatoid arthritis and found that their bodies might not respond well to growth hormone, which could affect their health.
Methodology
A pilot case-control study with blood sampling every 20 minutes for 24 hours in women with active RA and matched controls.
Potential Biases
The homogeneity of the study population may not represent all demographics.
Limitations
The study had a small sample size and strict inclusion criteria, limiting generalizability.
Participant Demographics
7 pre- and perimenopausal women with active RA, predominantly Hispanic-American and African-American.
Statistical Information
P-Value
0.0037 for GH half-life, 0.05 for IGF-I.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website